A Phase I study of MEDI-575, a PDGFRα monoclonal antibody, in Japanese patients with advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-015-2832-6
Published Online: 2015-07-30
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Murakami, Haruyasu
Ikeda, Masafumi
Okusaka, Takuji
Inaba, Yoshitaka
Iguchi, Haruo
Yagawa, Katsuro
Yamamoto, Nobuyuki
Funding for this research was provided by:
AstraZeneca
Text and Data Mining valid from 2015-07-30